|
|||||
|
|
Clinical efficacy of daratumumab,pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients |
|
| Authors: | Ajay K. Nooka Nisha S. Joseph Jonathan L. Kaufman Leonard T. Heffner Vikas A. Gupta Charise Gleason Lawrence H. Boise Sagar Lonial |
| Affiliation: | Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia |
| Abstract: | |
| Keywords: | daratumumab pomalidomide refractory myeloma relapsed and refractory myeloma re-treatment |